Amany M Hamed

4PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Genetically modified horticulture plantsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 27, 2026
Novel N-4-(5-Amino-7-substituted-triazolotriazinepiperazin-1-yl) Norfloxacin Analogues Exhibit Potent and Selective Anticancer Activity via Topoisomerase Inhibition, Cell-Cycle Arrest, and Apoptosis in A 431 Skin Carcinoma Cells.

|May 13, 2026
Chitosan-Based Taurine Nanoparticles Alleviate Dexamethasone-Induced Pulmonary-Thyroid Axis Dysfunction via Redox-Inflammatory Signaling Modulation in Rats.

|Nov 27, 2025
Melittin Nanoparticles Mitigate Glyphosate-Induced Nephrotoxicity via Cytokine Modulation and Bax/Nrf2 Pathways.

Amany M Hamed, Zeyad Elsayed Eldeeb Mohana, Azza M A Abouelella

|Jul 29, 2025
Novel Benzenesulfonamide Derivatives of 5'-Aminospirotriazolotriazine Exhibit Anti-Inflammatory Activity by Suppressing Pro-Inflammatory Mediators: In Vitro and In Vivo Evaluation Using a Rat Model of Carrageenan-Induced Paw Edema.

Amany M Hamed, Souhaila S Enaili, Walaa I Mohammed

Pageof 1

Frequent Collaborators

3 joint publications

Elsayed Eldeeb Mehana Hamouda

2 joint publications

Zeyad Elsayed Eldeeb Mohana

2 joint publications

Ahmed M El-Saghier

2 joint publications

Ahmed Mohamed Mahmoud Abdelfattah Elkassas